The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for high-risk, clinically significant PCa (csPCa), resulting in overdiagnosis and overtreatment of non-csPCa. Early identification of csPCa while avoiding unnecessary...
Dr. Alexander Kretschmer, MD, discusses the clinical interpretation and value of the ExoDx Prostate test (EPI test). The non-invasive, urine-based genomic test is a risk assessment tool that helps physicians and patients determine whether a prostate biopsy is necessary when PSA screening provides...
[54] Beshiri M L, Tice C M, Tran C, et al. A PDX/organoid biobank of advanced prostate cancers captures genomic and phenotypic heterogeneity for disease modeling and therapeutic screening[J]. Clin Cancer Res, 2018, 2...
Rheumatoid Arthritis Dx, Bariatric Surgery and Mortality, Prostate Cancer ScreeningMedicine in Brief summarizes discoveries, clinical tests, or guidelines published in internal...Current PsychiatryDowden Health Media, Inc.Current Psychiatry
Usually of the hand or wrist; bony erosions and localized decalcifications are Osteoarthritis (OA) is characterized by bony hypertrophy, whereas with RA affected joints tendK NishimuraCurrentpsychiatry Com